Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367

Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365

To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-07 2021-02-23 125824
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-17 2017-10-24 15995
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-26 2017-11-13 17331
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-28 2018-01-22 31039
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-19 2022-10-14 167421
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-02-02 177600
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-15 2019-02-21 72363
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-24 2019-06-21 82337
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-15 2019-06-24 84159
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-06-05 2019-06-21 85619
APO-TELMISARTAN 80MG TABLET Resolved 2017-05-24 2017-10-03 11047
APO-TELMISARTAN 40MG TABLET Resolved 2017-06-06 2017-10-03 12080
APO-TELMISARTAN 40MG TABLET Resolved 2018-07-11 2018-07-11 55290
APO-TELMISARTAN 40MG TABLET Resolved 2018-07-15 2018-09-12 55794
APO-TELMISARTAN 80MG TABLET Resolved 2018-07-15 2018-09-12 55798
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Resolved 2017-03-13 2017-03-31 748
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Resolved 2017-04-11 2018-09-12 6524
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Resolved 2017-05-04 2018-09-12 8922
APO-TELMISARTAN/HCTZ 25MG 80MG TABLET Actual shortage 2017-05-24 2018-12-20 11050
APO-TENOFOVIR 300MG TABLET Resolved 2018-07-25 2018-09-04 56538
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-HYDROXYQUINE 200MG TABLET Discontinued 2018-09-07 2018-10-05 60524
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557